A variety of factors have been investigated as possible causes of insulin-induced lipoatrophy, but the exact cause is still obscure. In a survey of 1096 consecutive diabetic patients of all ages, who had taken insulin for one year or longer, 24% had atrophy in some degree [1] . Such atrophy gives the appearance of subcutaneous fat having actually melted away and has been described as ,,a sharply defined disappearance of the subcutaneous fat without exudative reaction and appreciable fibrosis" [2, 3] .
One of our patients was a female diabetic with grossly disfiguring insulin atrophy and, during a period of treatment of 61/4 years, we attempted not only to reduce the atrophy, but also, by using a series of purified insulins with different characteristics, to elucidate the mechanism of atrophy induction and reduction.
Case Report
The patient (M.S.), a married French woman, 50 years of age, was first seen in 1967, at the age of 45, complaining of severe atrophy at the sites of insulin injections in the lateral upper aspects of her thighs. Three months prior to the occurrence of the lesions she had been placed on Semilente (Novo) and later on a combination of Semilente and Lente insulin (Novo). This was the first time that this patient had received insulin.
Physical examination revealed localized areas of lipoatrophy in the lateral and upper aspects of both thighs, measuring 5 cm in depth and covering an area of 6 • 10 cm. At the base of the atrophied areas muscle fascia could be palpated and no subcutaneous adipose tissue could be felt. The borders of the regions were sharply delineated and showed no inflammatory reaction (Fig. 1.) . The patient was put on a 1800 calorie diet (carbohydrate: 210 g, protein: 80 g, and fat: 65g). with 10 units of Semilente (Novo)and 18 units of Lente (Novo). The blood glucose values varied between 67 and 252 rag/100 ml. Her diabetes was of the stable type, but there was tendency for hypoglycaemia to develop in the forenoon.
During the 61/4 year's observation period, 9 series of regimes were followed (Fig. 2) .
Special Investigations

Biopsies of Adipose Tissue
During treatment period 6 and 7, biopsies of the adipose tissue were performed. Histology from the borders of the atrophy showed normal adipose tissue with normal capillaries and no cellular infiltration. There was no evidence of insulin antibodies when using an immunofluoreseeut technique. Adipose tissue was incubated with the monospecies beef insulin used at that time and, after washing, was treated with fluorescent insulin antibodies [4] . No immunochemical reaction was observed in the adipose tissue, including capillaries and arterioles (Prof. Hess, Depart. for Immunopathology, Path. Institute, University of Bern).
Insulin Antibodies
Insulin antibodies were determined frequently from the beginning of MC-insulin treatment [5] . The range with the various insulins is shown in Fig. 2 . There seems to be no relation between the stage of lipoatrophy and the level of insulin antibodies. The highest values were measured during the last reparatory phase on Monotard. 
Skin Test
Skin tests were performed with all relevant insulins, insulin components, and solvents, and no significant allergies were noted in comparison to histamine (1 : 10000).
Insulin Preparations and Methods
The following insulins were kindly supplied by Novo Industri A/S, Copenhagen: Monotard; 10 times recrystallized pork insulin Semilente and Lente; 4 times recrystallized pork insulin Lente; 4 times recrystallized beef insulin Lente; 10 times recrystallized beef insulin Lente. Insulin antibodies were measnred according to the method of Skom and Talmage [5] . 1 The immunofiuorescent examination of adipose tissue was carried out by the method of Coons [4] ; bloodglucose determinations were performed with glucose oxidase. Skin tests with Novo preparations were made at the Institute for Allergy and Clinical Immunology (Prof. A. de Weck) of the University of Bern.
Discussion
Lipoatrophy occurs in about one third of all insulin treated diabetics, mostly females. In most cases its development follows a common pattern, in that it appears after three to six months of treatment and subsides after 2--3 years, thus suggesting a spontaneous desensitization, as seen in cases of skin allergy to insulin. Only a few cases of marked atrophy are seen after the age of twenty. Such resistant and severe forms of insulin atrophy are rare and suggest the presence of overriding idiosyncratic factors. Knowles stated in a recent review [6] that the occurrence of lipoatrophy is decreasing. This may be due to use of more purified insulins. Nevertheless, there has been no satisfactory method of treating resistant forms. many factors which might be related to atrophy have been investigated in the course of m a n y years. It has been noted that the condition is not related to insulin pH, to the presence of preservatives such as tricresol in the insulin or to the presence of a ]ipase in exogenous insulin, to inflammatory processes, to the mechanical trauma of injections or to traces of alcohol, which might have been left in the syringe before the insulin was drawn [2, 3] .
There is still no satisfactory explanation for its pathogenesis [7] .
Insulin atrophy occurs in susceptible persons regardless of the variety of insulins used at present, with the exception of MC-insulin, with which we have not seen any atrophy. No cases have been reported in the literature to our knowledge. Our case report seems to indicate that the so-called" "impurities" of insulin, including proinsulin, may be the causative factor in susceptible individuals.
Even with commercial, reerystallized insulins (Novo), such as Semilente (pork) and Lente (beef/ pork), a t r o p h y may occur, as in our case. We found marked improvement of atrophy with MC-insulin, which is the purest insulin, free of all non-insulin components, including proinsulin, arginyl insulin, etc. and is virtually non-immunogenic [10] . As there was also no recurrence of atrophy with 10 times recrystallized pork insulin during an eight month period, we feel that pork proinsulin is probably not the factor responsible for the atrophy. But there are other insulin fractions in commercial pork insulins (Actrapid, Semilente) which may be the cause. In our patient 15" A. Teuscher: Insulin Lipoatrophy and Monocomponent Insulin beef insulin (4 times recrystallized MS beef Lente) seemed to show no adverse effects during the first 6 months of treatment, but then marked atrophy occurred while the patient was still on the same batch. It seems likely that beef insulin impurities, more immunogenic than pork insulin impurities, are also more harmful with regard to the development of lipoatrophy and, furthermore, that the amount and nature of impurities may vary in conventional insulins.
In five other female diabetics with insulin induced lipoatrophy of long duration (2 to 8 years), the lesions disappeared after 2 to 10 months' treatment with MC-insulin. In three patients, one of two symmetrical lesions was treated by injecting them from the periphery and within the atrophic areas and the beneficial effect occured only on the treated side.
